These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87. Metastatic inefficiency: the scientific basis for resection of liver metastases from colorectal cancer. Sugarbaker PH J Surg Oncol Suppl; 1993; 3():158-60. PubMed ID: 8503973 [TBL] [Abstract][Full Text] [Related]
88. Nisamycin, a new manumycin group antibiotic from Streptomyces sp. K106. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties. Hayashi K; Nakagawa M; Nakayama M J Antibiot (Tokyo); 1994 Oct; 47(10):1104-9. PubMed ID: 7961159 [TBL] [Abstract][Full Text] [Related]
89. The effect of divalent cations on Cloudman melanoma cells. Borovanský J; Riley PA Eur J Cancer Clin Oncol; 1983 Jan; 19(1):91-9. PubMed ID: 6682780 [TBL] [Abstract][Full Text] [Related]
91. Propagation of a poorly differentiated human pulmonary adenocarcinoma in nude athymic rats. Korsgaard R; Lindén CJ; Willén R; Willén H; Svensson G; Simonsson BG Int J Cancer; 1983 Dec; 32(6):793-9. PubMed ID: 6654530 [TBL] [Abstract][Full Text] [Related]
92. Coordinated mRNA expression of c-Kit with tyrosinase and TRP-1 in melanin pigmentation of normal and malignant human melanocytes and transient activation of tyrosinase by Kit/SCF-R. Luo D; Chen H; Searles G; Jimbow K Melanoma Res; 1995 Oct; 5(5):303-9. PubMed ID: 8541720 [TBL] [Abstract][Full Text] [Related]
93. Differential effects of 5-bromodeoxyuridine on B16 mouse melanoma cells. Sugita Y; Takeuchi T J Dermatol; 1982 Oct; 9(5):375-81. PubMed ID: 6761379 [No Abstract] [Full Text] [Related]
94. Histone deacetylase inhibitors up-regulate the expression of cell surface MHC class-I molecules in B16/BL6 cells. Komatsu Y; Hayashi H J Antibiot (Tokyo); 1998 Jan; 51(1):89-91. PubMed ID: 9531994 [No Abstract] [Full Text] [Related]
95. Correlation of cytotoxicity with elimination of iodine-125 from nude mice inoculated with prelabeled human melanoma cells. Lockshin A; Giovanella BC; Quian C; Mendoza JT; Vardeman DM; Stehlin JS J Natl Cancer Inst; 1984 Aug; 73(2):417-22. PubMed ID: 6589433 [TBL] [Abstract][Full Text] [Related]
96. Ectopic production of "pregnancy-specific" beta-1 glycoprotein in vitro: discordance with three other placental proteins. Rosen SW; Kaminska J; Calvert IS; Ellmore N; Aaronson SA Am J Obstet Gynecol; 1980 Jul; 137(5):525-9. PubMed ID: 7386546 [TBL] [Abstract][Full Text] [Related]
97. Synthesis and degradation of tyrosinase in cultured melanoma cells. Saeki H; Oikawa A J Cell Physiol; 1980 Aug; 104(2):171-5. PubMed ID: 6773969 [TBL] [Abstract][Full Text] [Related]
98. A multicenter phase II clinical trial using dacarbazine and continuous infusion interleukin-2 for metastatic melanoma. Clinical data and immunomonitoring. Dummer R; Gore ME; Hancock BW; Guillou PJ; Grobben HC; Becker JC; Oskam R; Dieleman JP; Burg G Cancer; 1995 Feb; 75(4):1038-44. PubMed ID: 7842406 [TBL] [Abstract][Full Text] [Related]
99. A cytokinetic model for heterogeneous mammalian cell populations. II. Tritiated thymidine studies: the per cent labeled mitosis (PLM) curve. Shackney SE J Theor Biol; 1974 Mar; 44(1):49-90. PubMed ID: 4822915 [No Abstract] [Full Text] [Related]
100. Differential regulation of gelatinase B and tissue-type plasminogen activator expression in human Bowes melanoma cells. Houde M; de Bruyne G; Bracke M; Ingelman-Sundberg M; Skoglund G; Masure S; van Damme J; Opdenakker G Int J Cancer; 1993 Feb; 53(3):395-400. PubMed ID: 8428793 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]